期刊文献+

围绝经期综合征与激素治疗进展 被引量:2

原文传递
导出
摘要 随着人口的老龄化,女性一生将有1/3或以上的时间在围绝经期与绝经后期渡过。绝经期卵巢功能衰退造成的雌激素不足,是促成老龄阶段慢性疾病的因素之一,这已是不争的事实,因此,绝经及其治疗应被看作公共健康的重要问题。
作者 张绍芬
出处 《中华全科医师杂志》 2008年第7期433-435,共3页 Chinese Journal of General Practitioners
  • 相关文献

参考文献10

  • 1Resnick SM, Maki PM, Rapp SR, et al. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab,2006,91 : 1802-1810.
  • 2Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women : principal results From the Women's Health Initiative randomized controlled trial. JAMA, 2002,288 : 321-333.
  • 3Women' s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy : the Women's Health Initiative randomized controlled trial. JAMA,2004,291 : 1701-1712.
  • 4Executive Committee of the International Menopause Society. Guidelines for the hormone treatment of women in the menopausal transition and beyond. Climacteric ,2004,7:8-11.
  • 5中华医学会妇产科分会绝经学组.绝经过渡期和绝经后激素治疗临床应用指南修订稿草案//中华医学会妇产科分会绝经学组.二次全国绝经相关问题高级学术研讨会,云南,2006.北京:中华医学会,2006:137-140.
  • 6Issued on behalf of the Board of the International Menopause Society . IMS updated recommendation on postmenopausal hormone therapy. Climacteric, 2007, 10 : 181-194.
  • 7Rossouw JE, Prentice RL, Manson JF, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA ,2007,297 : 1465-1477.
  • 8Canonico M, Oger E, Plu-Bureau G, et al. Hormone therapy and venous thromboembolism among postmenopausal women:impact of route of estrogen administration and progestogens: the ESTHER study. Circulation,2007,115:840-845.
  • 9Foumier A, Berrino F, Clavel-Chapelon F. Uniqual risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat ,2008 , 107 : 103-111.
  • 10Gambaeeiani M, Genazzani AR. Hormone replacement therapy: the benefits in tailoring the regimen and dose. Maturitas, 2001,40: 195 -201.

同被引文献26

  • 1陈松娥,彭峰林,邓树勋.有氧运动12周干预绝经后妇女体质形态及功能指标[J].中国组织工程研究与临床康复,2007,11(39):7924-7927. 被引量:5
  • 2谢幸,苟文丽.妇产科学[M].第8版.北京:人民卫生出版社,2013:258-264.
  • 3Llaneza P, Garcia-Portilla MP, Llaneza-Sudrez D, et al. Depres- sive disorders and the menopause transition [J]. Maturitas, 2012,71(2): 120-130.
  • 4Maclaran K, Stevenson JC. Primary prevention of cardiovascular disease with HRT [J]. Women Health(Lond Engl), 2012, 8(1):63-74.
  • 5Bittner V. Menopause age and cardiovascular risk : a complex re- lationship[ J ]. J Am CoU Cardao1,2009,54 (25) : 2374-2375.
  • 6Reekelhoff JF, Maric C. Sex and gender differences in cardiovas- cular- renal physiology and pathophysiology [ J ]. Steroids, 2010, 75(11) :745-746.
  • 7中国实用妇科中华老年全科SperoffL,FritzMA.临床妇科内分泌学与不孕[M].李继俊,译.6版.济南:山东科学技术出版社,2003:492-493.
  • 8Sturdee DM, Pines A. Updated IMS recommendations on post- menopausal hormone therapy and preventive strategies for midlife health [ J ]. Climacteric, 2011,14(3) : 302-320.
  • 9Meng X, Dai X, Liao TD, et al. Dose-dependent toxic effects of high-dose estrogen on renal and cardiac injury in surgically postmenopausal mice [J ]. Life Sci, 2011,88(3-4) : 178-186.
  • 10Demirol A, Baykal C, Kirazli S, et al. Effects of hormone re- placement on hemostasis in spontaneous menopause [J ]. Meno- pause,2001,8(2) : 135-140.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部